Loading clinical trials...
Loading clinical trials...
A Prospective Study for the Collection of Whole Blood Samples to Support the Development and Validation of In Vitro Diagnostic Tests for Dengue
The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.
Age
12 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Start Date
October 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
April 1, 2026
Last Updated
October 2, 2025
200
ESTIMATED participants
Lead Sponsor
Abbott Rapid Dx
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06665035